|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tarassishin L, Casper D and Lee SC:
Aberrant expression of interleukin-1β and inflammasome activation
in human malignant gliomas. PLoS One. 9:e1034322014. View Article : Google Scholar
|
|
3
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mantovani A: Cancer: Inflaming metastasis.
Nature. 457:36–37. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ozaki E, Campbell M and Doyle SL:
Targeting the NLRP3 inflammasome in chronic inflammatory diseases:
Current perspectives. J Inflamm Res. 8:15–27. 2015.PubMed/NCBI
|
|
7
|
Kolb R, Liu GH, Janowski AM, Sutterwala FS
and Zhang W: Inflammasomes in cancer: A double-edged sword. Protein
Cell. 5:12–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Okamoto M, Liu W, Luo Y, Tanaka A, Cai X,
Norris DA, Dinarello CA and Fujita M: Constitutively active
inflamma-some in human melanoma cells mediating autoinflammation
via caspase-1 processing and secretion of interleukin-1beta. J Biol
Chem. 285:6477–6488. 2010. View Article : Google Scholar :
|
|
9
|
Zhu Z, Zhong S and Shen Z: Targeting the
inflammatory pathways to enhance chemotherapy of cancer. Cancer
Biol Ther. 12:95–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng XF, Wang XL, Tian XJ, Yang ZH, Chu
GP, Zhang J, Li M, Shi J and Zhang C: Nod-like receptor protein 1
inflammasome mediates neuron injury under high glucose. Mol
Neurobiol. 49:673–684. 2014. View Article : Google Scholar
|
|
11
|
Fortin CF, Ear T and McDonald PP:
Autocrine role of endogenous interleukin-18 on inflammatory
cytokine generation by human neutrophils. FASEB J. 23:194–203.
2009. View Article : Google Scholar
|
|
12
|
Rivollier A, Mazzorana M, Tebib J, Piperno
M, Aitsiselmi T, Rabourdin-Combe C, Jurdic P and Servet-Delprat C:
Immature dendritic cell transdifferentiation into osteoclasts: A
novel pathway sustained by the rheumatoid arthritis
microenvironment. Blood. 104:4029–4037. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Y, Arora A, Min W, Roifman CM and
Grunebaum E: EdU incorporation is an alternative non-radioactive
assay to [(3)H] thymidine uptake for in vitro measurement of mice
T-cell proliferations. J Immunol Methods. 350:29–35. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Tania M, Khan MA and Fu J: epithelial to
mesenchymal transition inducing transcription factors and
metastatic cancer. Tumour Biol. 35:7335–7342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zitvogel L, Kepp O, Galluzzi L and Kroemer
G: Inflammasomes in carcinogenesis and anticancer immune responses.
Nat Immunol. 13:343–351. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Janowski AM, Kolb R, Zhang W and
Sutterwala FS: Beneficial and Detrimental Roles of NLRs in
Carcinogenesis. Front Immunol. 4:3702013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strowig T, Henao-Mejia J, Elinav E and
Flavell R: Inflammasomes in health and disease. Nature.
481:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allen IC, TeKippe EM, Woodford RM, Uronis
JM, Holl EK, Rogers AB, Herfarth HH, Jobin C and Ting JP: The NLRP3
inflammasome functions as a negative regulator of tumorigenesis
during colitis-associated cancer. J exp Med. 207:1045–1056. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang A, Wang P, Ma X, Yin X, Li J, Wang
H, Jiang W, Jia Q and Ni L: Mechanisms that lead to the regulation
of NLRP3 inflammasome expression and activation in human dental
pulp fibroblasts. Mol Immunol. 66:253–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sagulenko V, Thygesen SJ, Sester DP, Idris
A, Cridland JA, Vajjhala PR, Roberts TL, Schroder K, Vince JE, Hill
JM, et al: AIM2 and NLRP3 inflammasomes activate both apoptotic and
pyroptotic death pathways via ASC. Cell Death Differ. 20:1149–1160.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maelfait J, Vercammen E, Janssens S,
Schotte P, Haegman M, Magez S and Beyaert R: Stimulation of
Toll-like receptor 3 and 4 induces interleukin-1beta maturation by
caspase-8. J exp Med. 205:1967–1973. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Antonopoulos C, El Sanadi C, Kaiser WJ,
Mocarski ES and Dubyak GR: Proapoptotic chemotherapeutic drugs
induce noncanonical processing and release of IL-1beta via
caspase-8 in dendritic cells. J Immunol. 191:4789–4803. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gringhuis SI, Kaptein TM, Wevers BA,
Theelen B, van der Vlist M, Boekhout T and Geijtenbeek TB: Dectin-1
is an extracellular pathogen sensor for the induction and
processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat
Immunol. 13:246–254. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li S, Sun R, Chen Y, Wei H and Tian Z:
TLR2 controls the development of hepatocellular carcinoma by
reducing interleukin-18-mediated immunosuppression. Cancer Res. Jan
19–2015.Epub ahead of print. View Article : Google Scholar
|
|
26
|
Saijo Y, Tanaka M, Miki M, Usui K, Suzuki
T, Maemondo M, Hong X, Tazawa R, Kikuchi T, Matsushima K, et al:
Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis
lung carcinoma by induction of angiogenic factors: In vivo analysis
of tumor-stromal interaction. J Immunol. 169:469–475. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang L, Zhang LF, Wu J, Xu SJ, Xu YY, Li
D, Lou JT and Liu MF: IL-1β-mediated repression of microRNA-101 is
crucial for inflammation-promoted lung tumorigenesis. Cancer Res.
74:4720–4730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fabbi M, Carbotti G and Ferrini S:
Context-dependent role of IL-18 in cancer biology and
counter-regulation by IL-18BP. J Leukoc Biol. 97:665–675. 2015.
View Article : Google Scholar
|
|
29
|
Rovina N, Hillas G, Dima E, Vlastos F,
Loukides S, Veldekis D, Roussos C, Alhanatis M and Bakakos P: VEGF
and IL-18 in induced sputum of lung cancer patients. Cytokine.
54:277–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim KE, Song H, Hahm C, Yoon SY, Park S,
Lee HR, Hur DY, Kim T, Kim CH, Bang SI, et al: expression of ADAM33
is a novel regulatory mechanism in IL-18-secreted process in
gastric cancer. J Immunol. 182:3548–3555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim KE, Song H, Kim TS, Yoon D, Kim CW,
Bang SI, Hur DY, Park H and Cho DH: Interleukin-18 is a critical
factor for vascular endothelial growth factor-enhanced migration in
human gastric cancer cell lines. Oncogene. 26:1468–1476. 2007.
View Article : Google Scholar
|
|
32
|
Kim J, Kim C, Kim TS, Bang SI, Yang Y,
Park H and Cho D: IL-18 enhances thrombospondin-1 production in
human gastric cancer via JNK pathway. Biochem Biophys Res Commun.
344:1284–1289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vidal-Vanaclocha F, Fantuzzi G, Mendoza L,
Fuentes AM, Anasagasti MJ, Martín J, Carrascal T, Walsh P, Reznikov
LL, Kim SH, et al: IL-18 regulates IL-1beta-dependent hepatic
melanoma metastasis via vascular cell adhesion molecule-1. Proc
Natl Acad Sci USA. 97:734–739. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Apte RN, Dotan S, Elkabets M, White MR,
Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y and Voronov E: The
involvement of IL-1 in tumorigenesis, tumor invasiveness,
metastasis and tumor-host interactions. Cancer Metastasis Rev.
25:387–408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martín MJ, Calvo N, de Boland AR and
Gentili C: Molecular mechanisms associated with PTHrP-induced
proliferation of colon cancer cells. J Cell Biochem. 115:2133–2145.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Will M, Qin AC, Toy W, Yao Z,
Rodrik-Outmezguine V, Schneider C, Huang X, Monian P, Jiang X, de
Stanchina E, et al: Rapid induction of apoptosis by PI3K inhibitors
is dependent upon their transient inhibition of RAS-ERK signaling.
Cancer Discov. 4:334–347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Johannessen M and Moens U: Multisite
phosphorylation of the cAMP response element-binding protein (CREB)
by a diversity of protein kinases. Front Biosci. 12:1814–1832.
2007.
|
|
38
|
Reddy VS, Valente AJ, Delafontaine P and
Chandrasekar B: Interleukin-18/WNT1-inducible signaling pathway
protein-1 signaling mediates human saphenous vein smooth muscle
cell proliferation. J Cell Physiol. 226:3303–3315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hosotani Y, Kashiwamura S, Kimura-Shimmyo
A, Sekiyama A, Ueda H, Ikeda T, Mimura O and Okamura H:
Interleukin-18 prevents apoptosis via PI3K/Akt pathway in normal
human keratinocytes. J Dermatol. 35:514–524. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fix C, Bingham K and Carver W: Effects of
interleukin-18 on cardiac fibroblast function and gene expression.
Cytokine. 53:19–28. 2011. View Article : Google Scholar :
|
|
41
|
Yang KY, Bae WS, Kim MJ, Bae YC, Kim YJ,
Kim HJ, Nam SH and Ahn DK: Participation of the central p38 and
ERK1/2 pathways in IL-1β-induced sensitization of nociception in
rats. Prog Neuropsychopharmacol Biol Psychiatry. 46:98–104. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Venkatesan B, Valente AJ, Reddy VS, Siwik
DA and Chandrasekar B: Resveratrol blocks interleukin-18-EMMPRIN
cross-regulation and smooth muscle cell migration. Am J Physiol
Heart Circ Physiol. 297:H874–H886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chang MC, Hung HP, Lin LD, Shyu YC, Wang
TM, Lin HJ, Chan CP, Huang CC and Jeng JH: Effect of interleukin-1β
on ICAM-1 expression of dental pulp cells: Role of PI3K/Akt,
MEK/ERK, and cyclooxygenase. Clin Oral Investig. 19:117–126. 2015.
View Article : Google Scholar
|
|
44
|
Yan B, Zhang W, Jiang LY, Qin WX and Wang
X: Reduced E-cadherin expression is a prognostic biomarker of
non-small cell lung cancer: A meta-analysis based on 2395 subjects.
Int J Clin exp Med. 7:4352–4356. 2014.
|
|
45
|
Wang R, Ke ZF, Wang F, Zhang WH, Wang YF,
Li SH and Wang LT: GOLPH3 overexpression is closely correlated with
poor prognosis in human non-small cell lung cancer and mediates its
metastasis through upregulating MMP-2 and MMP-9. Cell Physiol
Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fiorentini C, Bodei S, Bedussi F, Fragni
M, Bonini SA, Simeone C, Zani D, Berruti A, Missale C, Memo M, et
al: GPNMB/OA protein increases the invasiveness of human metastatic
prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9
activity. Exp Cell Res. 323:100–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bandapalli OR, Ehrmann F, Ehemann V, Gaida
M, Macher-Goeppinger S, Wente M, Schirmacher P and Brand K:
Down-regulation of CXCL1 inhibits tumor growth in colorectal liver
metastasis. Cytokine. 57:46–53. 2012. View Article : Google Scholar
|
|
48
|
Gogali A, Charalabopoulos K, Zampira I,
Konstantinidis AK, Tachmazoglou F, Daskalopoulos G, Constantopoulos
SH and Dalavanga Y: Soluble adhesion molecules E-cadherin,
inter-cellular adhesion molecule-1, and E-selectin as lung cancer
biomarkers. Chest. 138:1173–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu Y and Zhou BP: Inflammation: A driving
force speeds cancer metastasis. Cell Cycle. 8:3267–3273. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kase S, Sugio K, Yamazaki K, Okamoto T,
Yano T and Sugimachi K: Expression of E-cadherin and beta-catenin
in human non-small cell lung cancer and the clinical significance.
Clin Cancer Res. 6:4789–4796. 2000.
|
|
51
|
Grant JL, Fishbein MC, Hong LS, Krysan K,
Minna JD, Shay JW, Walser TC and Dubinett SM: A novel molecular
pathway for Snail-dependent, SPARC-mediated invasion in non-small
cell lung cancer pathogenesis. Cancer Prev Res (Phila). 7:150–160.
2014. View Article : Google Scholar
|
|
52
|
Lee CH, Chang JS, Syu SH, Wong TS, Chan
JY, Tang YC, Yang ZP, Yang WC, Chen CT, Lu SC, et al: IL-1β
promotes malignant transformation and tumor aggressiveness in oral
cancer. J Cell Physiol. 230:875–884. 2015. View Article : Google Scholar
|
|
53
|
Jee YS, Jang TJ and Jung KH: Prostaglandin
E(2) and interleukin-1β reduce E-cadherin expression by enhancing
snail expression in gastric cancer cells. J Korean Med Sci.
27:987–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bani-Hani AH, Leslie JA, Asanuma H,
Dinarello CA, Campbell MT, Meldrum DR, Zhang H, Hile K and Meldrum
KK: IL-18 neutralization ameliorates obstruction-induced
epithelial-mesenchymal transition and renal fibrosis. Kidney Int.
76:500–511. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Helmy A, Guilfoyle MR, Carpenter KLH,
Pickard JD, Menon DK and Hutchinson PJ: Recombinant human
interleukin-1 receptor antagonist in severe traumatic brain injury:
A phase II randomized control trial. J Cereb Blood Flow Metab.
34:845–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang CC, Li H, Zhang M, Li XL, Yue LT,
Zhang P, Zhao Y, Wang S, Duan RN, Li YB, et al: Caspase-1 inhibitor
ameliorates experimental autoimmune myasthenia gravis by innate
dendric cell IL-1-IL-17 pathway. J Neuroinflammation. 12:1182015.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gu H, Xie M, Xu L, Zheng X, Yang Y and Lv
X: The protective role of interleukin-18 binding protein in a
murine model of cardiac ischemia/reperfusion injury. Transpl Int.
28:1436–1444. 2015. View Article : Google Scholar : PubMed/NCBI
|
